Equate Genomics

Akashi Therapeutics, based in Cambridge, is a global biopharmaceutical company with a focus on developing innovative therapies for individuals affected by rare disorders. The company's mission is to create life-changing treatments that address the unmet medical needs of those living with rare diseases, aiming to improve the quality of life for patients worldwide. Generated from their website's infomation

CliniWorks Inc., based in Cambridge, MA, specializes in advanced healthcare solutions, offering a comprehensive suite of products such as the AccelTeleHealth platform, which enhances telemedicine services for patients and healthcare providers. The company's innovative technologies are designed to integrate seamlessly with existing medical systems, enabling efficient data management and improved patient outcomes. With a strong focus on clinical research, CliniWorks facilitates patient recruitment for studies and supports healthcare organizations in achieving quality compliance and safety through robust analytics. Their commitment to personalized medicine and population health management underscores their role as a leader in the healthcare technology landscape. Generated from the website

Seven Bridges Genomics Inc, now known as Velsera, is a leading biomedical data company based in Charlestown, MA. Specializing in software and data analytics, they provide end-to-end bioinformatic solutions for public and private healthcare research, offering access to datasets, analytic workflows, cloud computing infrastructure, and scientific support to expedite the path from raw experimental data to new treatments and diagnostics. The company's innovative offerings include immediate access to a wide range of public datasets and bioinformatics tools, collaboration capabilities to fuel research and development, streamlined clinical trial research processes, and comprehensive security features to ensure genomic information remains safe and compliant with regulatory requirements. With a focus on accelerating biomarker discovery, advancing human genome research, and driving collaboration across institutions, Velsera empowers researchers in biopharma, government, and academia to make impactful strides in the field of genomics. Generated from the website